The largest database of trusted experimental protocols

Lactate dehydrogenase ldh assay

Manufactured by Promega
Sourced in United States

Lactate dehydrogenase (LDH) assay is a laboratory test used to measure the activity of the enzyme lactate dehydrogenase in a sample. LDH is an enzyme involved in the conversion of lactate to pyruvate during cellular metabolism. The assay provides a quantitative measurement of LDH levels, which can be used as an indicator of tissue damage or certain medical conditions.

Automatically generated - may contain errors

7 protocols using lactate dehydrogenase ldh assay

1

Characterization of BMAL1 Circadian Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
All reagents and chemicals were obtained from Sigma-Aldrich (now Merck) unless stated otherwise. REV-ERB agonist SR9009 was purchased from Calbiochem, US, dissolved in dimethyl sulfoxide (DMSO) and cytotoxicity determined by a Lactate dehydrogenase (LDH) assay (Promega, UK) or MTT assay (Sigma, UK). The lenti-shBmal1 plasmid was purchased from Abmgood (UK). Recombinant ACE2-Fc was previously reported (Zhou et al., 2020 (link)). The BMAL1 promoter luciferase reporter vector was purchased from Addgene, UK (Plasmid #46824) and contains 1 kb of BMAL1 upstream region and 53 nucleotides of exon 1, fused in-frame to the luciferase coding region followed by 1 kb of Bmal1 3′UTR. This construct has been widely used in circadian research (Brown et al., 2005 (link); Bu et al., 2018 (link); Sanghani et al., 2020 ; Schmitt et al., 2018 (link)). The Cry1 promoter construct and BMAL1/CLOCK expression plasmids were a gift of Ximing Qin, Anhui University, Hefei, China. The Cry1 promoter was amplified from genomic DNA using forward primer: 5′-ATCCTCGAGGTAAAGATGCACATGTGGCCCTG-3′ and reverse primer: 5′-CTAAAGCTTCGTCCGGAGGACACGCATACC-3′ and cloned into the pGL3 luciferase reporter vector (Promega, UK). The Bmal1 expression plasmid was previously described (Yang et al., 2020 ) and further engineered with a Flag tag. The Clock expression plasmid was previously described (Schoenhard et al., 2003 (link)).
+ Open protocol
+ Expand
2

Neuroprotective Effects of NPs on Microglia-Mediated Toxicity

Check if the same lab product or an alternative is used in the 5 most similar protocols
BV2 microglia were plated in a 96-well plate at 20,000 cells/well, and SH-SY5Y cells were plated separately in a 96-well plate at 15,000 cells/well. Microglia were treated with 20 µM of fAβ in the presence or absence of NPs for 24 h. In parallel, other wells were either treated with vehicle (1% FBS media plus PBS) or with 10 ng/ml LPS. The BV2-conditioned media (CM) from this experiment were harvested and used to treat SH-SY5Y cells for 24 h. The neurotoxicity in response to BV2-CM was quantified in SH-SY5Y cells using the lactate dehydrogenase (LDH) assay (Promega) and normalized to the fAβ-treated SH-SY5Y cells and to the SH-SY5Y cells exposed to CM of untreated BV2 cells.
+ Open protocol
+ Expand
3

Curcumin Effects on Macrophage Inflammation

Check if the same lab product or an alternative is used in the 5 most similar protocols
RAW 264.7 macrophages were seeded at 20,000 cells/well in a 96-well plate in DMEM supplemented with 10% FBS and 1% p-s and were allowed to adhere overnight. Cells were then treated for 1 hour with either blank PPS microspheres or curcumin-loaded PPS microspheres in fresh DMEM medium (phenol red-free, 1% FBS, 1% p-s) at a curcumin concentration of 3.4 μM, and then the media was supplemented with 100 ng/mL of LPS and 100 U/mL of IFN-γ for an additional 2 hours to stimulate production of ROS. Unstimulated cells were used as a control. After incubation with microspheres and LPS/IFN-γ, the treatments were removed and the cells were given fresh, phenol-red free DMEM (1% FBS, 1% p-s). After 24 hours of incubation, culture media was harvested for measurement of monocyte chemoattractant protein-1 (MCP-1) concentration using an ELISA kit (PeproTech). Protein concentration was normalized to relative cell number using a lactate dehydrogenase (LDH) assay (Promega) performed on lysed cells (KDalert lysis buffer, Life Technologies).
+ Open protocol
+ Expand
4

Hippocampal Neural Stem Cell Aβ Toxicity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adult rat hippocampal neural stem cells (Chemicon International Inc., Billerica, Mass.) were grown in DMEM/Ham’s F-12 medium containing B27 supplements without Vitamin A (Gibco®, Life Technologies, Carlsbad, Calif.). Cells were differentiated in DMEM/F12 medium containing N2 supplements (Gibco®) for 4 days. Cells were then treated with aggregated Aβ WT and mutants at 1, 10, and 50 μM concentrations for 24 hours. Media was collected from the cells and used in the lactate dehydrogenase (LDH) assay (Promega, Madison, Wis.). Assessment of membrane permeabilization was carried out in triplicate as previously described [67 (link)], using calcein dye as an indicator (Invitrogen).
+ Open protocol
+ Expand
5

Chromium Toxicity Assays in HepG2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells (1 × 105) were plated in the 24-well plate with 500 μL of medium, and were allowed to grow to 80%–90% confluence. HepG2 cells were exposed to different concentrations of K2Cr2O7 for 24 h. Cr(VI) working solution was prepared in Dulbecco’s Modified Eafle’s medium (DMEM) to reach final concentrations of 0, 5, 10, 20, 40, or 80 μM. Resazurin reduction assay was performed to determine cell viability after Cr(VI) treatment. Fifty microliters of resazurin (1 mg/mL stock) was added to the 24-well plates (500 μL/well), which were incubated for 2 h at 37 °C. Fifty microliters of color changed medium was transferred from each well to a 96-well plate and fluorescence was measured at 530 nm/590 nm (excitation/emission), using a multi-well fluorometric reader CytoFluor series 4000 (Applied Biosystems, Drive Foster, CA, USA). Lactate dehydrogenase (LDH) assay (Promega, Madison, WI, USA) was performed to determine cytotoxicity after Cr(VI) treatment. Fifty microliters of medium was transferred from each well to a 96-well plate and 50 μL of substrate mix was added to each well. The 96-well plate was then incubated for 30 min at room temperature. Subsequently, 50 μL of stop solution was added to each well and absorbance was measured at 560 nm using a plate reader. Data are presented as mean ± SEM. Three independent experiments in three replicates were performed.
+ Open protocol
+ Expand
6

Characterizing Lung Fibroblast Responses to Inflammatory Stimuli

Check if the same lab product or an alternative is used in the 5 most similar protocols
At passage 3–5, PAFs were grown to confluence in DMEM10% fetal calf serum (FCS) (Invitrogen, Burlington, ON, Canada) on collagen I (Corning, New York, NY, USA) coated 6-well plates. Cells were serum-deprived overnight and stimulated with/without 1 ng/mL recombinant IL-1α/β or IL-33 for 24 hours, which was determined following dose experiments (see Supplementary Fig. S14). Cell-culture supernatant, protein-lysates and RNA were harvested for ELISAs, western blots and qRT-PCR.
collagen I gels were made as previously described23 (link). 50,000 PAFs were seeded on top and allowed to migrate into and contract the gels. Cells were stimulated with 10 mg/ml β-aminopropionitrile (BAPN) (see Supplementary Fig. S15) or 1 ng/ml IL-1α,-β or IL-33 for 24 hours. Cell-seeded gels were assessed for contraction using Image J software and gel weight using a fine balance26 (link). A lactate dehydrogenase (LDH) assay (Promega, Madison, USA) to determine cell viability after cell stimulation, was done according to the manufacturer’s instructions.
+ Open protocol
+ Expand
7

In Vitro Ischemia-Reperfusion Injury Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
mBMECs were subjected to oxygen-glucose deprivation (OGD) injury. Injury was initiated by placing cultures in an anaerobic chamber (O2 level 0–5 ppm; Coy Laboratory, Great Lake MI) in the presence of OGD media (DMEM glucose free solution purged with an anaerobic gas mixture, 5% CO2/95%N2 and 10% H2, to remove residual oxygen) for 5 h at 37 °C. This was denoted as the ischemic condition. Then, cultures were removed from the chamber, medium exchanged with oxygenated DMEM, and cells placed in an incubator at 37 °C, with 5% CO2-containing normal oxygen (21% O2) to mimic reperfusion for 0 to 48 h. This was denoted as the reoxygenation condition. For every set of experiments, viability assays were performed (Lactate Dehydrogenase (LDH) Assay, Promega WI). Only cell cultures with cell viability of ~95% after OGD exposure, were used in experiments (Andjelkovic et al., 2003 (link); Dimitrijevic et al., 2006 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!